A pilot study examining molecular and clinical effects of aromatase inhibitor therapy on skeletal muscle function in early stage breast cancer

Study Overview

This research is being done to study how a type of breast cancer medicine called aromatase inhibitors (AI) affect muscle function in patients with breast cancer

Study Description

The purpose of this study is to learn more about the effects that aromatase inhibitors have on muscle function in patients with breast cancer.

Additional Information

Participants will be compensated for their participation.


  • IRB Number: 1801852430 (IUSCC-0647)
  • Research Study Identifier: TX8793
  • Principal Investigator: Tarah Ballinger, MD

Recruitment Status

Open

Contact the research team to learn more about this study.

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

If you need assistance finding a study or if you have any questions, please email: ctsirro@iu.edu or call us at (317) 278-2176